Invested in VocaVibe, a voice-biomarker AI system for diagnosing and monitoring neurodegenerative diseases.
VocaVibe is developing non-invasive, AI-driven diagnostic and monitoring solutions for Parkinson's disease (PD) using vocal biomarkers
VocaVibe is developing non-invasive, AI-driven diagnostic and monitoring solutions for Parkinson's disease (PD) using vocal biomarkers. Its core technology leverages artificial intelligence, including deep learning, machine learning, natural language processing, and voice & speech recognition, along with acoustic sensing.